CVS Health Corporation (CVS)
What Analyst Projections for Key Metrics Reveal About CVS Health (CVS) Q4 Earnings
Besides Wall Street's top-and-bottom-line estimates for CVS Health (CVS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights
The latest trading day saw CVS Health (CVS) settling at $75.24, representing a -2.07% change from its previous close.
Will Pharmacy and Consumer Wellness Segment Lead CVS' Q4 Earnings?
CVS Health may report higher Q4 revenues, led by prescription growth and expanded pharmacy operations.
CVS Health: Exploit The Sector Panic Ahead Of Earnings
CVS Health remains well-positioned despite a sector-wide selloff after disappointing Medicare rate increases and UnitedHealth's outlook. CVS's early restructuring, cost cuts, and reduced Medicare exposure have prepared it better than peers for current industry headwinds. At 10–11x forward earnings, CVS trades at a discount to peers, with potential for multiple expansion if execution continues.
CVS Health (CVS) Expected to Beat Earnings Estimates: Should You Buy?
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note
CVS Health (CVS) closed the most recent trading day at $74.03, moving +2.82% from the previous trading session.
Is CVS Stock The Best Of The Worst?
CVS stock fell by 14% on January 27 after the CMS revealed a modest 0.09% rate increase for 2027, which was a considerable disappointment compared to investor predictions of 4-6%. Although CVS's 14% drop was significant, it was not as severe as the over 20% declines seen at UnitedHealth and Humana.
Health insurers tumble after Trump administration proposes keeping Medicare Advantage rates flat next year
Shares of several big-name health care companies plunged after the Trump administration proposed nearly flat rates for Medicare Advantage insurers. In extended trading, Humana, CVS Health and UnitedHealth Group saw their shares slide by more than 10%.
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CVS Health (CVS) Exceeds Market Returns: Some Facts to Consider
CVS Health (CVS) concluded the recent trading session at $82.68, signifying a +1.46% move from its prior day's close.
CVS Health (CVS) Exceeds Market Returns: Some Facts to Consider
CVS Health (CVS) closed at $81.36 in the latest trading session, marking a +2.56% move from the prior day.
